HMOX1 and stroke disorder: Antioxidant agents driving the upregulation of HO-1, such as dimethyl fumarate [50], gastrodin [51], and thioredoxin [52], have been reported beneficial in models of stroke and also reduce microglial activation and stroke-related neuroinflammation.